🚨 $BIOA
BioAge Labs, Inc. recently announced that the first participant has been dosed in QUELL-DME, a randomized, controlled Phase 2 trial evaluating once-daily oral BGE-102, an NLRP3 inhibitor, in adults with diabetic macular edema , and provided updates on the QUELL-DME Phase 2 trial design.
BioAge Labs, Inc. recently announced that the first participant has been dosed in QUELL-DME, a randomized, controlled Phase 2 trial evaluating once-daily oral BGE-102, an NLRP3 inhibitor, in adults with diabetic macular edema , and provided updates on the QUELL-DME Phase 2 trial design.
SEC Filing: BIOA
Click to view the official SEC document.
www.sec.gov
October 2, 2026 at 9:09 PM
🚨 $BIOA
BioAge Labs, Inc. recently announced that the first participant has been dosed in QUELL-DME, a randomized, controlled Phase 2 trial evaluating once-daily oral BGE-102, an NLRP3 inhibitor, in adults with diabetic macular edema , and provided updates on the QUELL-DME Phase 2 trial design.
BioAge Labs, Inc. recently announced that the first participant has been dosed in QUELL-DME, a randomized, controlled Phase 2 trial evaluating once-daily oral BGE-102, an NLRP3 inhibitor, in adults with diabetic macular edema , and provided updates on the QUELL-DME Phase 2 trial design.
BioAge Labs to Present at Upcoming Investor Conferences
EMERYVILLE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for…
EMERYVILLE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for…
BioAge Labs to Present at Upcoming Investor Conferences
EMERYVILLE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for…
news-area.com
September 26, 2026 at 8:59 AM
BioAge Labs to Present at Upcoming Investor Conferences
EMERYVILLE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for…
EMERYVILLE, Calif., Sept. 25, 2026 (GLOBE NEWSWIRE) -- BioAge Labs, Inc. (NASDAQ: BIOA) ("BioAge", "the Company"), a clinical-stage biotechnology company developing therapeutic product candidates for…
Just In: a16z's Capital Management fund is down nearly $67,250,000 today
Their holdings:
$BTGO -6.8%
$KLRA -6.4%
$RBLX -4.0%
$META -3.7%
$MAZE -2.6%
$AKTS -1.9%
$DNA -1.5%
$ERAS -1.0%
$FIG -0.6%
$SPCX -0.6%
$DMRA -0.6%
$BIOA -0.5%
$XYZ -0.2%
$CAMP +0.3%
$OMDA +0...
🔗 twitter.com/i/status/209844...
Their holdings:
$BTGO -6.8%
$KLRA -6.4%
$RBLX -4.0%
$META -3.7%
$MAZE -2.6%
$AKTS -1.9%
$DNA -1.5%
$ERAS -1.0%
$FIG -0.6%
$SPCX -0.6%
$DMRA -0.6%
$BIOA -0.5%
$XYZ -0.2%
$CAMP +0.3%
$OMDA +0...
🔗 twitter.com/i/status/209844...
September 25, 2026 at 3:53 PM
Just In: a16z's Capital Management fund is down nearly $67,250,000 today
Their holdings:
$BTGO -6.8%
$KLRA -6.4%
$RBLX -4.0%
$META -3.7%
$MAZE -2.6%
$AKTS -1.9%
$DNA -1.5%
$ERAS -1.0%
$FIG -0.6%
$SPCX -0.6%
$DMRA -0.6%
$BIOA -0.5%
$XYZ -0.2%
$CAMP +0.3%
$OMDA +0...
🔗 twitter.com/i/status/209844...
Their holdings:
$BTGO -6.8%
$KLRA -6.4%
$RBLX -4.0%
$META -3.7%
$MAZE -2.6%
$AKTS -1.9%
$DNA -1.5%
$ERAS -1.0%
$FIG -0.6%
$SPCX -0.6%
$DMRA -0.6%
$BIOA -0.5%
$XYZ -0.2%
$CAMP +0.3%
$OMDA +0...
🔗 twitter.com/i/status/209844...
元論文→ Reference: Voß J, Rockmann L, Meyer V, et al. The magnetic removal of PFAS from water − from molecules to microplastics. Mater Today. 2026;99:103471. doi: 10.1016/j.mattod.2026.103471
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
The magnetic removal of PFAS from water − from molecules to microplastics
Per- and polyfluoroalkyl substances (PFAS), known as “forever chemicals”, pose a persistent environmental threat due to their chemical stability, bioa…
www.sciencedirect.com
September 23, 2026 at 11:45 PM
元論文→ Reference: Voß J, Rockmann L, Meyer V, et al. The magnetic removal of PFAS from water − from molecules to microplastics. Mater Today. 2026;99:103471. doi: 10.1016/j.mattod.2026.103471
www.sciencedirect.com/science/arti...
www.sciencedirect.com/science/arti...
#SolucionesComunitarias En Quintana Roo, pescadores instalaron hidrófonos en el fondo marino para grabar al mero del Caribe durante su época de reproducción y así protegerlos. Sin embargo, el calentamiento del mar está cambiando el comportamiento de esta especie. es.mongabay.com/2026/09/bioa...
El rugido del mar: bioacústica comunitaria para entender cómo el cambio climático afecta al pez mero del Caribe en México
Los efectos del cambio climático en el mero del Caribe mexicano se revelan gracias a la bioacústica comunitaria.
es.mongabay.com
September 23, 2026 at 7:17 PM
#SolucionesComunitarias En Quintana Roo, pescadores instalaron hidrófonos en el fondo marino para grabar al mero del Caribe durante su época de reproducción y así protegerlos. Sin embargo, el calentamiento del mar está cambiando el comportamiento de esta especie. es.mongabay.com/2026/09/bioa...
Bioactive Bone Void Filler Market Size, Trends & Growth 2035 | WiseGuyReports www.wiseguyreports.com/reports/bioa...
www.wiseguyreports.com
September 23, 2026 at 9:59 AM
Bioactive Bone Void Filler Market Size, Trends & Growth 2035 | WiseGuyReports www.wiseguyreports.com/reports/bioa...
Chemical #priming of #hypoxia responses via PLANT CYSTEINE OXIDASE inhibition improves #flooding tolerance
academic.oup.com/plphys/artic...
#PlantScience @plantphys.bsky.social @aspbofficial.bsky.social @planteditors.bsky.social @isplore.bsky.social @plant-sci.bsky.social @sciplant.bsky.social
academic.oup.com/plphys/artic...
#PlantScience @plantphys.bsky.social @aspbofficial.bsky.social @planteditors.bsky.social @isplore.bsky.social @plant-sci.bsky.social @sciplant.bsky.social
Chemical priming of hypoxia responses via PLANT CYSTEINE OXIDASE inhibition improves flooding tolerance
Abstract. Extreme flooding driven by climate change demands strategies to enhance plant tolerance to low-oxygen stress. We investigated the ability of bioa
academic.oup.com
September 21, 2026 at 2:37 PM
Chemical #priming of #hypoxia responses via PLANT CYSTEINE OXIDASE inhibition improves #flooding tolerance
academic.oup.com/plphys/artic...
#PlantScience @plantphys.bsky.social @aspbofficial.bsky.social @planteditors.bsky.social @isplore.bsky.social @plant-sci.bsky.social @sciplant.bsky.social
academic.oup.com/plphys/artic...
#PlantScience @plantphys.bsky.social @aspbofficial.bsky.social @planteditors.bsky.social @isplore.bsky.social @plant-sci.bsky.social @sciplant.bsky.social
BIOA (BIOA) technical analysis: support, resistance, RSI, MACD, moving averages, and volume. Full breakdown at tickzen.app. Educational content only — not financial advice.
September 18, 2026 at 7:35 PM
BIOA (BIOA) technical analysis: support, resistance, RSI, MACD, moving averages, and volume. Full breakdown at tickzen.app. Educational content only — not financial advice.
Chemical priming of hypoxia responses via PLANT CYSTEINE OXIDASE inhibition improves flooding tolerance (Francesco Fioriti , Rocco Pierpaolo Germano , Noemi La Monaca , et al) doi.org/10.1093/plph... #PlantScience @aspbofficial
Chemical priming of hypoxia responses via PLANT CYSTEINE OXIDASE inhibition improves flooding tolerance
Abstract. Extreme flooding driven by climate change demands strategies to enhance plant tolerance to low-oxygen stress. We investigated the ability of bioa
doi.org
September 18, 2026 at 6:11 PM
Chemical priming of hypoxia responses via PLANT CYSTEINE OXIDASE inhibition improves flooding tolerance (Francesco Fioriti , Rocco Pierpaolo Germano , Noemi La Monaca , et al) doi.org/10.1093/plph... #PlantScience @aspbofficial
TEE-SET - MA BELLE AMIE
YouTube video by CENTERTAINMENTmusic
www.youtube.com
September 17, 2026 at 8:35 PM
Bioactive Fillings Market Size, Share, Trends, Report 2035 www.marketresearchfuture.com/reports/bioa...
Bioactive Fillings Market Size, Share & Growth Report 2035 | MRFR
The Bioactive Fillings market is projected to grow from USD Billion 1.86 in 2024 to USD Billion 3.491 by 2035, at a CAGR of 5.89% during 2025-2035.
www.marketresearchfuture.com
September 16, 2026 at 7:19 AM
Bioactive Fillings Market Size, Share, Trends, Report 2035 www.marketresearchfuture.com/reports/bioa...
Bioabsorbable Screw Systems Market Size, Share & Trends 2035 | WiseGuyReports www.wiseguyreports.com/reports/bioa...
Bioabsorbable Screw Systems Market Size, Share & Trends 2035
The Bioabsorbable Screw Systems Market is expected to grow from 1,000 USD Million in 2025 to 2,500 USD Million by 2035. The Bioabsorbable Screw Systems Market CAGR (growth rate) is expected to be arou...
www.wiseguyreports.com
September 15, 2026 at 8:43 AM
Bioabsorbable Screw Systems Market Size, Share & Trends 2035 | WiseGuyReports www.wiseguyreports.com/reports/bioa...
1 new message www.marketresearchfuture.com/reports/bioa...
Bioabsorbable Orthopedic Implant Market Size, Share & Growth Report 2035 | MRFR
The Bioabsorbable Orthopedic Implant market is projected to grow from USD Billion 1.202 in 2024 to USD Billion 5.612 by 2035, at a CAGR of 15.03% during 2025-2035.
www.marketresearchfuture.com
September 15, 2026 at 6:28 AM
1 new message www.marketresearchfuture.com/reports/bioa...
BioAge Labs $BIOA
~0.6% of the portfolio
~$79,244,997
Clinical-stage biotech developing drugs aimed at the biology of metabolic aging
~0.6% of the portfolio
~$79,244,997
Clinical-stage biotech developing drugs aimed at the biology of metabolic aging
September 11, 2026 at 4:13 PM
BioAge Labs $BIOA
~0.6% of the portfolio
~$79,244,997
Clinical-stage biotech developing drugs aimed at the biology of metabolic aging
~0.6% of the portfolio
~$79,244,997
Clinical-stage biotech developing drugs aimed at the biology of metabolic aging
Bioactive Fillings Market Size, Share, Trends, Report 2035 www.marketresearchfuture.com/reports/bioa...
Bioactive Fillings Market Size, Share & Growth Report 2035 | MRFR
The Bioactive Fillings market is projected to grow from USD Billion 1.86 in 2024 to USD Billion 3.491 by 2035, at a CAGR of 5.89% during 2025-2035.
www.marketresearchfuture.com
September 10, 2026 at 10:30 AM
Bioactive Fillings Market Size, Share, Trends, Report 2035 www.marketresearchfuture.com/reports/bioa...
Bioactive Fillings Market Size, Share, Trends, Report 2035 www.marketresearchfuture.com/reports/bioa...
Bioactive Fillings Market Size, Share & Growth Report 2035 | MRFR
The Bioactive Fillings market is projected to grow from USD Billion 1.86 in 2024 to USD Billion 3.491 by 2035, at a CAGR of 5.89% during 2025-2035.
www.marketresearchfuture.com
September 8, 2026 at 1:40 PM
Bioactive Fillings Market Size, Share, Trends, Report 2035 www.marketresearchfuture.com/reports/bioa...
September 7, 2026 at 9:44 AM
Another paper from my lab! Are you trying to reconstruct the consensus sequences of whatever viruses may be in a given sample (e.g. wastewater, patient collection) from a large collection of viruses of interest (e.g. Flu, RSV, SARS-CoV-2, etc.)? Check out MultiVirusConsensus! doi.org/10.1093/bioa...
MultiVirusConsensus: An accurate and efficient open-source pipeline for identification and consensus sequence generation of multiple viruses from mixed samples
AbstractMotivation. Viral surveillance from mixed samples (e.g. wastewater) has become critical in public health efforts to track and contain pathogens. Ho
doi.org
September 3, 2026 at 1:41 PM
Another paper from my lab! Are you trying to reconstruct the consensus sequences of whatever viruses may be in a given sample (e.g. wastewater, patient collection) from a large collection of viruses of interest (e.g. Flu, RSV, SARS-CoV-2, etc.)? Check out MultiVirusConsensus! doi.org/10.1093/bioa...
Nos conseils pour vos itinéraires de rentrée 🚗🚫
➡️ https://l.actu.fr/bIoa
➡️ https://l.actu.fr/bIoa
August 31, 2026 at 5:22 PM
Nos conseils pour vos itinéraires de rentrée 🚗🚫
➡️ https://l.actu.fr/bIoa
➡️ https://l.actu.fr/bIoa
#BIOA #BIOAB Number of shares and votes in BioArctic AB (publ) as of August 31, 2026
https://www.stocktitan.net/news/BIOA/number-of-shares-and-votes-in-bio-arctic-ab-publ-as-of-august-31-d0p6zca1uc0j.html
https://www.stocktitan.net/news/BIOA/number-of-shares-and-votes-in-bio-arctic-ab-publ-as-of-august-31-d0p6zca1uc0j.html
Number of shares and votes in BioArctic AB (publ) as of August 31, 2026
BioArctic (Nasdaq Stockholm: BIOA B) issued 20,200 new Class B shares in August 2026 following the exercise of 20,200 stock options from the 2019/2028 program approved on May 9, 2019. As of August 31, 2026, BioArctic had a total of 88,744,685 shares outstanding, comprising 74,344,689 listed Class B shares and 14,399,996 unlisted Class A shares. Class A shares carry ten votes per share and Class B shares one vote per share, giving a total of 218,344,649 votes in the company.
www.stocktitan.net
August 31, 2026 at 3:57 PM
#BIOA #BIOAB Number of shares and votes in BioArctic AB (publ) as of August 31, 2026
https://www.stocktitan.net/news/BIOA/number-of-shares-and-votes-in-bio-arctic-ab-publ-as-of-august-31-d0p6zca1uc0j.html
https://www.stocktitan.net/news/BIOA/number-of-shares-and-votes-in-bio-arctic-ab-publ-as-of-august-31-d0p6zca1uc0j.html